SCHEMBL30565236

SCHEMBL30565236

Cc1cnc(Cl)nc1Nc1cccc(S(=O)(=O)N2CCOCC2)c1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KCNA5 P22460 2/20 0.61
▸ MEN1 O00255 3/20 0.52
▸ KMT2A Q03164 3/20 0.52
▸ POLB P06746 2/20 0.52
▸ ATM Q13315 1/20 0.52
▸ PKM P14618 1/20 0.52
▸ LMNA P02545 1/20 0.50
▸ TDP1 Q9NUW8 1/20 0.50
▸ RXFP1 Q9HBX9 1/20 0.49
▸ ALDH1A1 P00352 4/20 0.49
▸ CCNT1 O60563 1/20 0.49
▸ CDK1 P06493 1/20 0.49
▸ CCNB1 P14635 1/20 0.49
▸ CCNA2 P20248 1/20 0.49
▸ CDK2 P24941 1/20 0.49
▸ CDK7 P50613 1/20 0.49
▸ CDK9 P50750 1/20 0.49
▸ CCNH P51946 1/20 0.49
▸ BRD4 O60885 1/20 0.49
▸ JAK2 O60674 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25382854 1.00 KCNA5 (0.61) KCNA5MEN1KMT2APOLBATM
SCHEMBL25381155 0.89 JAK1 (0.59) KCNA5POLBPKMCCNT1CDK1
SCHEMBL270247 0.84 BRD4 (0.54) KCNA5POLBPKMRXFP1ALDH1A1
SCHEMBL10267648 0.84 JAK1 (0.53) KCNA5POLBPKMRXFP1ALDH1A1
SCHEMBL30565217 0.81 BRD4 (0.69) CDK7CDK9BRD4JAK2JAK1
SCHEMBL25381910 0.81 JAK1 (0.55) LMNACCNT1CDK1CCNB1CCNA2
SCHEMBL25381831 0.81 BRD4 (0.69) CDK7CDK9BRD4JAK2JAK1
SCHEMBL30565221 0.81 BRD4 (0.69) CDK7CDK9BRD4JAK2JAK1
SCHEMBL25383250 0.81 BRD4 (0.69) CDK7CDK9BRD4JAK2JAK1
SCHEMBL30565219 0.81 JAK1 (0.55) LMNACCNT1CDK1CCNB1CCNA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4673149-A1 NEW COMPOUNDS AND TREATMENT OF RENAL CELL CARCINOMA Trustlife Global Inc. (US) 2026-01-07 — — EP disclosed
EP-4486348-A1 NEW COMPOUNDS AND TREATMENT OF RENAL CELL CARCINOMA Trustlife Global Inc. (US) 2025-01-08 — — EP disclosed
CN-118804751-A New compounds and treatment of renal cell carcinoma 巴什生物技术公司 2024-10-18 — — CN disclosed
WO-2024179699-A1 NEW COMPOUNDS AND TREATMENT OF RENAL CELL CARCINOMA BASH BIOTECH INC. (US) 2024-09-06 — — WO disclosed
WO-2023166153-A1 NEW COMPOUNDS AND TREATMENT OF RENAL CELL CARCINOMA BASH BIOTECH INC (US) 2023-09-07 — — WO disclosed
Send feedback